News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Hineline Lawrence J.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/07/2023 |
4/A
| Hineline Lawrence J. (SVP of Finance CFO) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Granted 40,472 options to buy
@ $53.63, valued at
$2.2M
|
|
| 06/16/2023 |
4
| Hineline Lawrence J. (SVP of Finance CFO) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Sold 34,227 shares
@ $63.35, valued at
$2.2M
Sold 44,035 shares
@ $64.37, valued at
$2.8M
Sold 3,592 shares
@ $65.01, valued at
$233.5k
Exercised 40,472 options to buy
@ $53.63, valued at
$2.2M
Exercised 25,082 options to buy
@ $23.94, valued at
$600.5k
Exercised 11,762 options to buy
@ $36.89, valued at
$433.9k
Exercised 4,538 options to buy
@ $56.73, valued at
$257.4k
|
|
| 03/13/2023 |
4
| Hineline Lawrence J. (SVP of Finance CFO) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Granted 15,663 shares
@ $0
Sold 12,963 shares
@ $43.17, valued at
$559.6k
Sold 2,700 shares
@ $42.52, valued at
$114.8k
Sold 5,324 shares
@ $44.97, valued at
$239.4k
Sold 258 shares
@ $44.14, valued at
$11.4k
Exercised 5,582 restricted stock units
@ $0 |
|
| 03/08/2023 |
4
| Hineline Lawrence J. (SVP of Finance CFO) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Granted 39,398 restricted stock units
@ $0 |
|
| 02/27/2023 |
4
| Hineline Lawrence J. (SVP of Finance CFO) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Sold 7,455 shares
@ $47.03, valued at
$350.6k
Exercised 7,455 restricted stock units
@ $0 |
|
| 02/22/2023 |
4
| Hineline Lawrence J. (SVP of Finance CFO) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Sold 52,279 shares
@ $49.81, valued at
$2.6M
Sold 1,689 shares
@ $50.59, valued at
$85.4k
Sold 8,649 shares
@ $46.54, valued at
$402.5k
Sold 800 shares
@ $47.32, valued at
$37.9k
Sold 900 shares
@ $48.72, valued at
$43.8k
Sold 94 shares
@ $49.6, valued at
$4.7k
Exercised 53,968 options to buy
@ $12.73, valued at
$687k
Exercised 10,443 restricted stock units
@ $0 |
|
| 09/23/2022 |
4
| Hineline Lawrence J. (SVP of Finance CFO) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Sold 31,861 shares
@ $45.88, valued at
$1.5M
Sold 33,303 shares
@ $45.39, valued at
$1.5M
Exercised 65,164 options to buy
@ $15.47, valued at
$1M
|
|
| 03/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/11/2022 |
4
| Hineline Lawrence J. (SVP of Finance CFO) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Sold 3,105 shares
@ $41.61, valued at
$129.2k
Sold 12,434 shares
@ $40.77, valued at
$506.9k
Sold 4,100 shares
@ $40.07, valued at
$164.3k
Exercised 19,639 restricted stock units
@ $0 |
|
| 12/23/2021 |
4
| Hineline Lawrence J. (SVP of Finance CFO) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Sold 25,462 shares
@ $48.67, valued at
$1.2M
Sold 100,803 shares
@ $47.84, valued at
$4.8M
Sold 35,135 shares
@ $46.91, valued at
$1.6M
Sold 9,200 shares
@ $45.81, valued at
$421.5k
Sold 3,800 shares
@ $44.95, valued at
$170.8k
Sold 600 shares
@ $44.28, valued at
$26.6k
Exercised 50,000 options to buy
@ $16.86, valued at
$843k
Exercised 72,120 options to buy
@ $17.57, valued at
$1.3M
Exercised 52,880 options to buy
@ $15.73, valued at
$831.8k
|
|
| 02/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/13/2020 |
4
| Hineline Lawrence J. (SVP of Finance CFO) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Sold 28,034 shares
@ $25.41, valued at
$712.3k
Exercised 10,000 options to buy
@ $2.84, valued at
$28.4k
Exercised 10,000 options to buy
@ $3.26, valued at
$32.6k
|
|
| 09/11/2020 |
4
| Hineline Lawrence J. (SVP of Finance CFO) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Sold 41,983 shares
@ $31.14, valued at
$1.3M
Exercised 26,983 options to buy
@ $12.73, valued at
$343.5k
|
|
| 02/20/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/28/2020 |
4
| Hineline Lawrence J. (SVP of Finance CFO) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Granted 8,043 shares
@ $0
Disposed of 3,809 shares
@ $23.61, valued at
$89.9k
|
|
| 01/10/2020 |
4
| Hineline Lawrence J. (SVP of Finance CFO) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Sold 19,638 shares
@ $26.16, valued at
$513.7k
|
|
| 01/08/2020 |
4
| Hineline Lawrence J. (SVP of Finance CFO) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Sold 3,867 shares
@ $29.8, valued at
$115.2k
Sold 17,591 shares
@ $30.4, valued at
$534.8k
Exercised 19,638 restricted stock units
@ $0 |
|
| 01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/08/2019 |
4
| Hineline Lawrence J. (SVP of Finance CFO) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Sold 19,716 shares
@ $11.42, valued at
$225.2k
Sold 1,742 shares
@ $11.84, valued at
$20.6k
Sold 3,108 shares
@ $12.42, valued at
$38.6k
Gifted 1,200 shares
@ $0
Exercised 3,108 restricted stock units
@ $0
Granted 80,951 options to buy
@ $12.73, valued at
$1M
Granted 58,915 restricted stock units
@ $0 |
|
| 01/03/2019 |
4
| Hineline Lawrence J. (SVP of Finance CFO) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Granted 7,807 shares
@ $0
Sold 7,807 shares
@ $11.09, valued at
$86.6k
Exercised 5,298 restricted stock units
@ $0
Exercised 16,160 restricted stock units
@ $0 |
|
| 02/20/2018 |
4
| Hineline Lawrence J. (VP of Finance CFO) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Sold 33,381 shares
@ $20.03, valued at
$668.6k
Sold 16,319 shares
@ $20.01, valued at
$326.5k
|
|
| 01/05/2018 |
4
| Hineline Lawrence J. (VP of Finance CFO) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Sold 3,192 shares
@ $15.67, valued at
$50k
Sold 1,870 shares
@ $17.49, valued at
$32.7k
Exercised 5,297 restricted stock units
@ $0
Exercised 3,108 restricted stock units
@ $0
Granted 65,164 options to buy
@ $15.47, valued at
$1M
Granted 48,480 restricted stock units
@ $0 |
|
| 01/09/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/04/2016 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities [Amend] |
| 09/09/2013 |
3
| Hineline Lawrence J. (VP of Finance, CFO & Secretary) has filed a Form 3 on Intra-Cellular Therapies, Inc. |
|
|